New Patent Applications. The Issuer shall procure that all New Patent applications owned by the Issuer or a Subsidiary of the Issuer incorporated or organized in the United Kingdom or under the laws of the United States, any state thereof or the District of Columbia, if not filed in the name of the relevant IPR SPV, will be assigned to the relevant IPR SPV concurrently with such application, or if that is not procedurally possible, as soon as reasonably practicable thereafter. The Issuer shall procure that each Subsidiary of the Issuer filing a Patent application in the United States, any state thereof, the District of Columbia or Germany notifies the Security Trustee of the relevant patent office details, the name of the patentee, the application number and the date of filing.
New Patent Applications. Notwithstanding Section 6.2(a), if after consultation with Xxxxxxx, Xxxxxxxx agrees that a new patent application (including, with respect to Sleeping Beauty Intellectual Property, a divisional application) should be filed based on the Licensed Know-How, such patent applications shall be deemed Licensed Patents subject to further prosecution and maintenance in accordance with Section 6.2(a). Precigen shall reasonably consult with Xxxxxxx regarding the drafting and filing of such new patent applications and shall reasonably consider any comments provided by Xxxxxxx related thereto. For the avoidance of doubt, Precigen shall have authority with respect to such new patent applications (or divisional application) filing, prosecution and maintenance decisions in accordance with Section 6.2(a).
New Patent Applications. Notwithstanding Section 7.4(a), if after consultation with Ziopharm, Precigen agrees that a new patent application (including, with respect to Sleeping Beauty Intellectual Property, a divisional application) should be filed based on the Licensed Know-How, such patent applications shall be deemed Licensed Patents subject to further prosecution and maintenance in accordance with Section 7.4(a). Precigen shall reasonably consult with Ziopharm regarding the drafting and filing of such new patent applications and shall reasonably consider any comments provided by Ziopharm related thereto. For the avoidance of doubt, Precigen shall have authority with respect to such new patent applications (or divisional application) filing, prosecution and maintenance decisions in accordance with Section 7.4(a). (c)
New Patent Applications. Whenever it deems it necessary or proper to do so, Licensee shall be entitled to cause a patent application relating to any new aspects or otherwise unpatented aspects of the Invention to be prepared and filed with the United States Patent and Trademark Office ("Patent Applications"). Each Patent Application shall be filed in Inventor's name as the inventor. Licensee shall control and direct the preparation and prosecution of all Patent Applications through Licensee's patent counsel and shall pay for the costs and expenses of each Patent Application. Inventor shall fully and completely cooperate with Licensee in the preparation, filing and prosecution of any Patent Application. This
New Patent Applications. On the request of PLL, LTC will apply for a Licensed Patent 5 in any country or jurisdiction in which a Licensed Patent has not been issued or applied for with respect to each of the Licensed Products or for the extension or continuation of any of the Patents. All expenses, including attorneys' fees, in connection with such an application shall be paid by LTC. At PLL's option and to the extent possible, PLL shall take over and prosecute in LTC's name any such application. PLL and LTC shall keep each other informed with respect to the progress of any applications made under this Section 5.5. All additional Licensed Patents, and all reissue Licensed Patents, Licensed Patents of addition, divisions, continuations, continuations-in-part and extensions of such Licensed Patents shall be the property of LTC and shall be included within the defined term "Licensed Patents". In the event that PLL shall request LTC to discontinue prosecuting any such application brought at PLL's request pursuant to this Section 5.5, LTC shall either discontinue it or pay all expenses in connection with prosecution arising after the date of such request. Nothing in this Section 5.5 shall limit LTC's rights to apply for any additional Licensed Patents, or for reissue Licensed Patents, Licensed Patents of addition, or divisions, continuations, continuations-in-part or extensions of any of the Licensed Patents. The provisions of this Agreement shall apply to any Licensed Patents obtained pursuant to this Section 5.5 and to any reissue Licensed Patents and Licensed Patents of addition, and to any divisions, continuations, continuations in-part and extensions thereof.
New Patent Applications. Whenever it deems it necessary or proper to do so, Licensee shall be entitled to cause a patent application relating to any new aspects or otherwise unpatented aspects of the Invention to be prepared and filed with the United States Patent and Trademark Office ("Patent Applications"). Each Patent Application shall be filed in Inventor's name as the inventor. Licensee shall control and direct the preparation and prosecution of all Patent Applications through Licensee's patent counsel and shall pay for the costs and expenses of each Patent Application. Inventor shall fully and completely cooperate with Licensee in the preparation, filing and prosecution of any Patent Application. This Section 3 shall also apply to any and all continuation, continuation-in-part, divisional and reissue patent applications which, in whole or in part or directly or indirectly, are based upon or claim any priority from the Licensed Patents or any Patent Application. The decision to file any such continuation, continuation-in-part, divisional or reissue patent application shall rest solely with Licensee.
New Patent Applications. 5.3.1 In the event and on each occasion that the TESTING of COMPOUNDS to be covered by the NEW PATENT APPLICATIONS reveals an effect that is not covered by the SENETEK PATENTS or issued INSTITUTE PATENTS or by the PATENT APPLICATION PCT/CZ02/00045 or PATENT APPLICATION PCT/CZ03/00078, or PATENT APPLICATION PCT/US2007/073142, or PATENT APPLICATION US 11/966,559, and that merits patent protection, the following arrangements shall apply:
5.3.2 The NEW PATENT APPLICATIONS will be filed in the name of INSTITUTE. The PARTIES intend to file NEW PATENT APPLICATIONS in China, Japan, South Korea, Taiwan, Vietnam, India, Australia, USA, Canada, Mexico, Brazil, Egypt, Saudi Arabia, and South Africa, as a European patent (including Hong Kong), in Israel, New Zealand, Norway, Philippines, Euro-Asian Patent and Singapore.
5.3.3 The PARTIES appointed COUNSEL to prosecute all documents for the preparation, filing, extension, delivery and maintenance of international and national patents based on NEW PATENT APPLICATIONS.
5.3.4 Each PARTY will bear patent protection costs in certain territories:
New Patent Applications. Notwithstanding Section 6.2(a), if after consultation with Axxxxxx, Pxxxxxxx agrees that a new patent application (including, with respect
New Patent Applications. Notwithstanding Section 7.4(a), if after consultation with Ziopharm, Precigen agrees that a new patent application (including, with respect to Sleeping Beauty Intellectual Property, a divisional application) should be filed based
New Patent Applications. 5.3.1 In the event and on each occasion that the TESTING of COMPOUNDS to be covered by the NEW PATENT APPLICATIONS reveals an effect that is not covered by the SENETEK PATENTS or issued INSTITUTE PATENTS or by the PATENT APPLICATION PCT/CZ02/00045 or PATENT APPLICATION PCT/CZ03/00078 and that merits patent protection, the following arrangements shall apply:
5.3.2 The NEW PATENT APPLICATIONS will be filed in the name of INSTITUTE. The PARTIES intend to file NEW PATENT APPLICATIONS in China, Japan, South Korea, Taiwan, Vietnam, India, Australia, USA, Canada, Mexico, Brazil, Egypt, Saudi Arabia, and South Africa, as a European patent (including Hong Kong), in Israel, New Zealand, Norway, Philippines, Euro-Asian Patent and Singapore.
5.3.3 The PARTIES appointed COUNSEL to prosecute all documents for the preparation, filing, extension, delivery and maintenance of international and national patents based on NEW PATENT APPLICATIONS.
5.3.4 Each PARTY will bear patent protection costs in certain territories:
